{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:22:42Z","timestamp":1761985362218,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T00:00:00Z","timestamp":1420588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/1745-6215-16-9","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:27:49Z","timestamp":1434612469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Imran B","family":"Chaudhry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raza","family":"ur Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Omair","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M","family":"Hamirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajmal","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakeel","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya H","family":"Buch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inti","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasir","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyeba","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salahuddin","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"issue":"2","key":"2389_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.57.2.3","volume":"57","author":"BN Cronstein","year":"2005","unstructured":"Cronstein BN: Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.Pharmacol Rev 2005,57(2):163\u201372. 10.1124\/pr.57.2.3","journal-title":"Pharmacol Rev"},{"issue":"21","key":"2389_CR2","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.172501499","volume":"99","author":"PT Ravi Rajagopalan","year":"2002","unstructured":"Ravi Rajagopalan PT, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes G: Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics.Proc Natl Acad Sci 2002,99(21):13481\u20136. 10.1073\/pnas.172501499","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2389_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","volume":"114","author":"A Johnston","year":"2005","unstructured":"Johnston A, Gudjonsson JE, Sigmundsdottir H, Runar Ludviksson B, Valdimarsson H: The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules.Clin Immunol 2005,114(2):154\u201363. 10.1016\/j.clim.2004.09.001","journal-title":"Clin Immunol"},{"issue":"1","key":"2389_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2005.02.040","volume":"151","author":"K Gong","year":"2006","unstructured":"Gong K, Zhang Z, Sun X, Zhang X, Li A, Yan J, Luo Q, Gao Y, Feng Y: The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.Am Heart J 2006,151(1):62\u20138. 10.1016\/j.ahj.2005.02.040","journal-title":"Am Heart J"},{"key":"2389_CR5","volume-title":"Mediators Inflamm","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Zhao P, Li A, Lv X, Gao Y, Sun H, Ding Y, Liu J: Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats.Mediators Inflamm 2009., 389720:"},{"issue":"8","key":"2389_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.bbi.2012.08.005","volume":"26","author":"S Busse","year":"2012","unstructured":"Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, Mawrin C, Schmitt A, Jordan W, M\u00fcller UJ, Bernstein HG, Bogerts B, Steiner J: Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?Brain Behav Immun 2012,26(8):1273\u20139. 10.1016\/j.bbi.2012.08.005","journal-title":"Brain Behav Immun"},{"issue":"9","key":"2389_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/0269881112444941","volume":"26","author":"IB Chaudhry","year":"2012","unstructured":"Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B: Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment.J Psychopharmacol 2012,26(9):1185\u201393. 10.1177\/0269881112444941","journal-title":"J Psychopharmacol"},{"issue":"8","key":"2389_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.Biol Psychiatry 2008,63(8):801\u20138. 10.1016\/j.biopsych.2007.09.024","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2389_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1440-1819.2012.02354.x","volume":"66","author":"RB Mansur","year":"2012","unstructured":"Mansur RB, Zugman A, Asevedo EM, da Cunha GR, Bressan RA, Brietzke E: Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages.Psychiatry Clin Neurosci 2012,66(4):247\u201360. 10.1111\/j.1440-1819.2012.02354.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"2389_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.Biol Psychiatry 2011, 70:663\u201371. 10.1016\/j.biopsych.2011.04.013","journal-title":"Biol Psychiatry"},{"key":"2389_CR11","doi-asserted-by":"publisher","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","volume":"28","author":"MM Behrens","year":"2008","unstructured":"Behrens MM, Ali SS, Dugan LL: Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia.J Neurosci 2008, 28:13957\u201366. 10.1523\/JNEUROSCI.4457-08.2008","journal-title":"J Neurosci"},{"key":"2389_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jneuroim.2004.10.026","volume":"160","author":"O Schulte-Herbruggen","year":"2005","unstructured":"Schulte-Herbruggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A: Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain derived neurotrophic factor in human monocytes.J Neuroimmunol 2005, 160:204\u20139. 10.1016\/j.jneuroim.2004.10.026","journal-title":"J Neuroimmunol"},{"issue":"6","key":"2389_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","volume":"20","author":"L Drzyzga","year":"2006","unstructured":"Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS: Cytokines in schizophrenia and the effects of antipsychotic drugs.Brain Behav Immun 2006,20(6):532\u201345. 10.1016\/j.bbi.2006.02.002","journal-title":"Brain Behav Immun"},{"key":"2389_CR14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1586\/ern.09.59","volume":"9","author":"HG Bernstein","year":"2009","unstructured":"Bernstein HG, Steiner J, Bogerts B: Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy.Expert Rev Neurother 2009, 9:1059\u201371. 10.1586\/ern.09.59","journal-title":"Expert Rev Neurother"},{"key":"2389_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","volume":"63","author":"A Monji","year":"2009","unstructured":"Monji A, Kato T, Kanba S: Cytokines and schizophrenia: microglia hypothesis of schizophrenia.Psychiatry Clin Neurosci 2009, 63:257\u201365. 10.1111\/j.1440-1819.2009.01945.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"279","key":"2389_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"2009","author":"AM Myint","year":"2012","unstructured":"Myint AM: Kynurenines: from the perspective of major psychiatric disorders.FEBS J 2012,2009(279):1375\u201385.","journal-title":"FEBS J"},{"key":"2389_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","volume":"50","author":"J Doorduin","year":"2009","unstructured":"Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC: Neuroinflammation in schizophrenia-related psychosis: a PET study.J Nucl Med 2009, 50:1801\u20137. 10.2967\/jnumed.109.066647","journal-title":"J Nucl Med"},{"key":"2389_CR18","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","volume":"64","author":"BN van Berckel","year":"2008","unstructured":"van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS: Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.Biol Psychiatry 2008, 64:820\u20132. 10.1016\/j.biopsych.2008.04.025","journal-title":"Biol Psychiatry"},{"key":"2389_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia.Schizophr Bull 1987, 13:261\u201376. 10.1093\/schbul\/13.2.261","journal-title":"Schizophr Bull"},{"key":"2389_CR20","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.","edition":"4"},{"key":"2389_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1192\/bjp.157.6.853","volume":"157","author":"M Birchwood","year":"1990","unstructured":"Birchwood M, The Social Functioning Scale: The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients.Br J Psychiatry 1990, 157:853\u20139. 10.1192\/bjp.157.6.853","journal-title":"Br J Psychiatry"},{"key":"2389_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","volume":"10","author":"DW Heinrichs","year":"1984","unstructured":"Heinrichs DW, Hanlon TE, Carpenter WT: The quality of life scale: an instrument for rating the schizophrenic deficit syndrome.Schizophr Bull 1984, 10:388\u201398. 10.1093\/schbul\/10.3.388","journal-title":"Schizophr Bull"},{"key":"2389_CR23","first-page":"574","volume-title":"Abstracts of the XX International Congress on Schizophrenia Research, April 2 \u2013 April 6, 2005, Volume 31","author":"BZ Yusufi","year":"2005","unstructured":"Yusufi BZ, Mukherjee S, Aitchison K, Dunn G, Page E, Barnes TR: Inter-rater reliability of the antipsychotic non-neurological side-effects rating scale (ANNSERS). In Abstracts of the XX International Congress on Schizophrenia Research, April 2 \u2013 April 6, 2005, Volume 31. Savannah, Georgia: Schizophr Bull; 2005:574."},{"key":"2389_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","volume":"43","author":"SL Whittle","year":"2004","unstructured":"Whittle SL, Hughes RA: Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.Rheumatology 2004, 43:267\u201371.","journal-title":"Rheumatology"},{"key":"2389_CR25","first-page":"36","volume":"25","author":"Z Ortiz","year":"1998","unstructured":"Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P: The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a meta-analysis of randomised controlled trials.J Rheumatol 1998, 25:36\u201343.","journal-title":"J Rheumatol"},{"key":"2389_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","volume":"121","author":"SL Morgan","year":"1994","unstructured":"Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, Koopman WJ, Krumdieck CL, Alarc\u00f3n GS: Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind placebo-controlled trial.Ann Intern Med 1994, 121:833\u201341. 10.7326\/0003-4819-121-11-199412010-00002","journal-title":"Ann Intern Med"},{"key":"2389_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1192\/bjp.159.2.271","volume":"159","author":"A Procter","year":"1991","unstructured":"Procter A: Enhancement of recovery from psychiatric illness by methylfolate.Br J Psychiatry 1991, 159:271\u20132. 10.1192\/bjp.159.2.271","journal-title":"Br J Psychiatry"},{"key":"2389_CR28","unstructured":"Harmonised Tripartite Guideline for Good Clinical Practice 1996 Geneva: International Federation of the Pharmaceutical Manufacturers Association; 1996."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-16-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-16-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-16-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T23:07:35Z","timestamp":1548112055000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-16-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2389"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-16-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2015,1,7]]},"assertion":[{"value":"20 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}